Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102724 · ClinicalTrials.gov registry record · NA
Fish Oil for HIV-Related Inflamm-aging and Immune Senescence
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02102724 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 37 participants.
The verdict
NCT02102724, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
HIV infection is associated with premature aging of the immune system. It is believe that the persistent inflammation that accompanies HIV infection is a major contributor to premature immune aging. Fish oil has well-documented anti-inflammatory properties. In this randomized, clinical trial, we're testing whether a 12-week course of fish oil supplementation will reverse premature aging in HIV-infected older adults.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Fish oil that contains omega-3 fatty acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02102724
The ClinicalTrials.gov registry entry for NCT02102724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02102724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02102724 about?
NCT02102724 is a clinical study titled "Fish Oil for HIV-Related Inflamm-aging and Immune Senescence". HIV infection is associated with premature aging of the immune system. It is believe that the persistent inflammation that accompanies HIV infection is a major contributor to premature immune aging. Fish oil has well-documented anti-inflammatory properties. In this randomized, clinical trial, we're ...
What is the current status of trial NCT02102724?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2014-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02102724?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Fish oil that contains omega-3 fatty acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02102724?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.